Applications of immunoassay methods to drug disposition studies

References

• Landsteiner K. The Specificity of Serological Reactions. Harvard University Press, Boston 1945, (Reprinted by Dover, New York, 1962)
   Google Scholar
• Berson S. A., Yalow R. S. Quantitative aspects of reaction between insulin and insulin-binding antibody. J. Clin. Invest. 1959; 38: 1996–2016
   PubMed Web of Science ®Google Scholar
• Yalow R. S., Berson S. A. Immunoassay of endogenous plasma insulin in man. J. Clin. Invest. 1960; 39: 1157–1175
   PubMed Web of Science ®Google Scholar
• Beiser S. M., Erlanger B. F., Agate F. J., Lieberman S. Antigenicity of steroid-protein conjugates. Science 1959; 129: 564–565
   PubMed Web of Science ®Google Scholar
• Oliver G. C., Jr., Parker B. M., Brasfield D. L., Parker C. W. The measurement of digitoxin in human serum by radio immunoassay. J. Clin. Invest. 1968; 47: 1035–1042
   PubMed Web of Science ®Google Scholar
• Mule S. J., Sunshine I., Braude M., Willette R. E. Immunoassays for Drugs Subject to Abuse. CRC Press, Cleveland, OH 1974
   Google Scholar
• Price C. P. Analytical techniques for therapeutic drug monitoring. Clin. Biochem. 1984; 17: 52–56
   PubMed Web of Science ®Google Scholar
• Smith F. P., Shaler R. C., Mortimer C. E., Errichetto L. T. Detection of drugs in bloodstains. II: morphine. J. Forensic Sci. 1980; 25: 369–373
   PubMed Web of Science ®Google Scholar
• Rutterford M. G., Smith R. N. Radioimmunoassay of diazepam in samples of forensic interest. J. Pharm. Pharmacol. 1980; 32: 449–452
   PubMed Web of Science ®Google Scholar
• Baumgartner A. M., Jones P. F., Baumgartner W. A., Black C. T. Radioimmunoassay of hair for determining opiate-abuse histories. J Nucl. Med. 1979; 20: 748–752
   PubMed Web of Science ®Google Scholar
• Westekemper P., Wieczorek U., Guerrita F., Langlois N., Langlois Y., Potier P., Zenk M. H. Radioimmunoassay for the determination of the indole alkaloid vindoline in Catharanthus. Planta Med. 1980; 39: 24–37
   Web of Science ®Google Scholar
• Weiler E. W. Radioimmunoassays for the differential and direct analysis of free and conjugated abscisic acid in plant extracts. Planta 1980; 148: 262–272
   PubMed Web of Science ®Google Scholar
• Maroy P., Vargha J., Horvath K. Rapid heterologous hapten radioimmunoassay for insect moulting hormone. FEBS. Lett. 1977; 81: 319–322
   PubMed Web of Science ®Google Scholar
• Nakamura R. M., Dito W. R., Tucker E. S. Immunoassays in the Clinical Laboratory. Alan R. Liss, New York 1979
   Google Scholar
• Nakamura R. M., Dito W. R., Tucker E. S. Immunoassays: Clinical Laboratory Techniques for the 1980s. Alan R. Liss, New York 1980
   Google Scholar
• Kirkham K. E., Hunter W. M. Radioimmunoassay Methods. Churchill Livingstone, Edinburgh/London 1973
   Google Scholar
• Odell W. D., Daughady W. H. Principles of Competitive Protein-Binding Assays. J. B. Lippincott, Philadelphia 1971
   Google Scholar
• Van Vunakis H., Langone J. J. Meth. Enzymol. 1980; 70
   PubMedGoogle Scholar
• Langone J. J., Van Vunakis H. Meth. Enzymol. 1982; 84
   Google Scholar
• O'Sullivan M. J., Bridges J. W., Marks V. Enzyme immunoassay: a review. Ann. Clin. Biochem. 1979; 16: 221–240
   PubMed Web of Science ®Google Scholar
• Butler V. P., Jr., Beiser S. M. Antibodies to small molecules: biological and clinical applications. Adv. Immunol. 1973; 17: 255–310
   PubMedGoogle Scholar
• Spector S. Radioimmunoassay. Ann. Rev. Pharmacol. 1973; 13: 359–370
   PubMedGoogle Scholar
• Erlanger B. F. Principles and methods for the preparation of drug protein conjugates for immunological studies. Pharmacol. Rev. 1973; 25: 271–280
   PubMed Web of Science ®Google Scholar
• Marks V., Morris B. A., Teale J. D. Pharmacology. Br. Med. Bull. 1974; 30: 80–86
   PubMed Web of Science ®Google Scholar
• Butler V. P., Jr. Drug immunoassays. J. Immunol. Methods 1975; 7: 1–24
   PubMed Web of Science ®Google Scholar
• Langone J. J., Van Vunakis H., Levine L. Antibodies: analytical tools to study pharmacologically active compounds. Accts. Chem. Res. 1975; 8: 335–342
   Web of Science ®Google Scholar
• Cleeland R., Christenson J., Usategui-Gomez M., Heveran J., Davis R., Grunberg E. Detection of drugs of abuse by radioimmunoassay: a summary of published data and some new information. Clin. Chem. 1976; 22: 712–725
   PubMed Web of Science ®Google Scholar
• Castro A., Malkus H. Radioimmunoassays of drugs of abuse in humans: a review. Res. Commun. Chem. Pathol. Pharmacol. 1977; 16: 291–309
   PubMedGoogle Scholar
• Landon J., Moffat A. C. The radioimmunoassay of drugs. A review. Analyst 1976; 101: 225–243
   PubMed Web of Science ®Google Scholar
• Butler V. P., Jr. The immunological assay of drugs. Pharmacol. Rev. 1978; 29: 103–184
   Web of Science ®Google Scholar
• Raso V. Radioimmunoassay of neocarzinostatin. Meth. Enzymol. 1982; 84: 483–490
   PubMed Web of Science ®Google Scholar
• Van Vunakis H., Farrow J. T., Gjika H. B., Levine L. Specificity of the antibody receptor site to cMysergamide: model of a physiological receptor for lysergic acid diethylamide. Proc. Nat. Acad. Sci. U.S.A. 1971; 68: 1483–1487
   PubMed Web of Science ®Google Scholar
• Nelson J. C., Berk L. S., Lewis J. E., Emori H. W. In-domethacin: measurement by radioimmunoassay. Clin. Res. 1976; 24: 151A
   Google Scholar
• Morris B. A., Robinson J. D., Piall E., Aherne G. W., Marks V. Development of a radioimmunoassay for morphine having minimal cross-reactivity with codeine. J. Endocrinol. 1975; 64: 6P–7P
   PubMed Web of Science ®Google Scholar
• Mojaverian P., Chase G. D. Production and characterization of specific antibody for radioimmunoassay of procainamide. J. Pharm. Sci. 1980; 69: 721–724
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., Butz R. F., Jones E. C. Relationships between immunogen structure and antisera specificity in the narcotic alkaloid series. Clin. Chem. 1981; 27: 1524–1535
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., Warren J. T., Hill J. A., Welch R. M. Stereospecific radioimmunoassays for d-pseudoephedrine in human plasma and their application to bioequivalency studies. J. Pharm. Sci. 1981; 70: 624–631
   PubMed Web of Science ®Google Scholar
• Langone J. J., Van Vunakis H. Meth. Enzymol. 1981; 73: 1–75
   PubMedGoogle Scholar
• Playfair J. H. L., Hum B. A. L., Schulster D. Production of antibodies and binding reagents. Br. Med. Bull. 1974; 30: 24–31
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., De Angelis R. L., Butz R. F., Sailstad J. B., Welch R. M. Disposition of phenacetin in dog and man determined by a sensitive and specific radioimmunoassay. J. Pharmacol. Exp. Ther. 1979; 210: 127–133
   PubMed Web of Science ®Google Scholar
• Fong K-L. L., Ho D. H. W., Carter C. J. K., Brown N. S., Benjamin R. S., Freireich E. J., Bodey G. P., Sr. Radioimmunoassay for the detection and quantitation of bruceantin. Anal. Biochem. 1980; 105: 281–286
   PubMed Web of Science ®Google Scholar
• Dixon W. R., Young R. L., Holazo A., Jack M. L., Weinfeld R. E., Alexander K., Liebman A., Kaplan S. A. Bumetanide: radioimmunoassay and pharmacokinetic profile in humans. J. Pharm. Sci. 1976; 65: 701–704
   PubMed Web of Science ®Google Scholar
• Cook C. E., Tallent C. R., Amerson E. W., Myers M. W., Kepler J. A., Taylor G. F., Christensen H. D. Caffeine in plasma and saliva by a radioimmunoassay procedure. J. Pharm. Exp. Ther. 1976; 199: 679–686
   PubMed Web of Science ®Google Scholar
• Ranee M. J., Robinson J. D., Taylor K. T. The preparation of 2H- and 3H-tertiary amines. J. Labelled Compd. Radio. Pharm. 1976; 12: 467–472
   Web of Science ®Google Scholar
• Cook C. E., Tallent C. R., Ballentine N. H., Taylor G. F., Kepler J. A. Synthesis of high specific activity R-warfarin and S-warfarin-3H. J. Labelled Compd. Radio. Pharm. 1979; 16: 623–631
   Web of Science ®Google Scholar
• Broughton A., Strong J. E. Radioimmunoassay of antibiotics and chemotherapeutic agents. Clin. Chem. 1976; 22: 726–732
   PubMed Web of Science ®Google Scholar
• Hunter W. M., Greenwood F. C. Preparation of iodine-131 labelled human growth hormone of high specific activity. Nature 1962; 194: 495–496
   PubMed Web of Science ®Google Scholar
• Hunter W. M. Preparation and assessment of radioactive tracers. Br. Med. Bull. 1974; 30: 18–23
   PubMed Web of Science ®Google Scholar
• Bolton A. E., Hunter W. M. The labelling of proteins to high specific radioactivities by conjugation to a 1251-containing acylating agent. Biochem. J. 1973; 133: 529–539
   PubMed Web of Science ®Google Scholar
• Broughton A., Strong J. E. Radioimmunoassay of iodinated gentamicin. Clin. Chim. Acta 1976; 66: 125–129
   PubMed Web of Science ®Google Scholar
• Broughton A., Strong J. E., Bodey G. P. Radioimmunoassay of sisomicin. Antimicrob. Agents Chemother. 1976; 9: 247–250
   PubMed Web of Science ®Google Scholar
• Warren J. T., Coker G. G., Welch R. M., Fowle A. S. E., Findlay J. W. A. Plasma levels of a novel antidysrhythmic agent, meobentine sulfate, in humans as determined by radioimmunoassay. J. Pharm. Sci. 1981; 71: 665–670
   Web of Science ®Google Scholar
• Goding J. W. Use of Staphylococcal protein A as an immunological reagent. J. Immunol. Meth. 1978; 20: 241–253
   PubMed Web of Science ®Google Scholar
• Sidki A. M., Smith D. S., Landon J. Dual-label fluoroim-munoassay for simultaneous determination of primidone and phenobarbital. Ther. Drug Monit. 1985; 7: 101–107
   PubMed Web of Science ®Google Scholar
• Fehskens E., Burgett M. W. Measurement of serum chorionic-gonadotropin by a biotin-avidin labeled enzyme-immunoassay. Ann. Clin. Lab. Sci. 1985; 15: 241–245
   PubMed Web of Science ®Google Scholar
• Goldstein S. A., Van Vunakis H. Determination of fluphenazine, related phenothiazine drugs and metabolites by combined high-performance liquid chromatography and radioim-munassay. J. Pharmacol. Exp. Ther. 1981; 217: 36–43
   PubMed Web of Science ®Google Scholar
• Robinson J. D., Wilson I. D., Bevan C. D., Chamberlain J. A novel use of RIA and HPLC in the identification of HR 158. Drug Metabolite Isolation and Determination, E. Reid, J. P. Leppard. Plenum Press, New York 1983; 111
   Google Scholar
• Yeager E. P., Goebelsmann V., Soares J. R., Grant J. D., Gross S. J. Δ9-Tetrahydrocannabionol by g.l.c-m.s.-validated radioimmunoassays of hemolyzed blood or serum. J. Anal. Toxicol. 1981; 5: 81–84
   PubMed Web of Science ®Google Scholar
• Nicolau G., Van Lear G., Kaul B., Davidow B. Determination of morphine by electron capture gas-liquid chromatography. Clin. Chem. 1977; 23: 1640–1643
   PubMed Web of Science ®Google Scholar
• Krause W., Jacobs U., Schulze P. E., Nieuweboer B., Humpel M. Development of antibody-mediated extraction followed by GC/MS (antibody/GC/MS) and its application to iloprost determination in plasma. Prostaglandins Leukotrienes Med. 1985; 17: 167–182
   PubMedGoogle Scholar
• Engvall E., Perlmann P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Im-munochemistry 1971; 8: 871–874
   PubMed Web of Science ®Google Scholar
• Van Weemen B. K., Schuurs A. H. W. M. Immunoassay using antigen-enzyme conjugates. FEBS Lett. 1971; 15: 232–236
   PubMed Web of Science ®Google Scholar
• Feldman G., Druet P., Bignan J., Avrameas S. Immunoenzymatk Techniques. North Holland/Elsevier, Amsterdam 1976
   Google Scholar
• Pal S. B. Enzyme Labelled Immunoassay of Hormones and Drugs. Walter de Gruyter, New York 1978
   Google Scholar
• Rubenstein K. E., Schneider R. S., Ullman E. F. “Homogenous” enzyme immunoassay. A new immunochemical technique. Biochem. Biophys. Res. Commun. 1972; 47: 846–851
   PubMed Web of Science ®Google Scholar
• Schneider R. S., Lindquist P., Wong E., Rubinstein K. E., Ullman E. Homogenous enzyme immunoassay for opiates in urine. Clin. Chem. 1973; 19: 821–825
   PubMed Web of Science ®Google Scholar
• Woodhead T. P. Chemiluminescence immunoassay. J. Clin. Immunol. 1984; 7: 82
   Google Scholar
• Whitehead T. P., Kricka L. J., Carter T. J. N., Thorpe G. H. G. Analytical luminescence: its potential in the clinical laboratory. Clin. Chem. 1979; 25: 1531–1546
   PubMed Web of Science ®Google Scholar
• Leute R. K., Ullman E. F., Goldstein A., Herzenberg L. A. Spin immunoassay technique for determination of morphine. Nature 1972; 236: 93–94
   Web of Science ®Google Scholar
• Adler F. L., Liu C.-T. Detection of morphine by hemagglutination inhibition. J. Immunol. 1971; 106: 1684–1685
   PubMed Web of Science ®Google Scholar
• Adler F. L., Liu C. T., Catlin D. H. Immunological studies on heroin addiction. I. Methodology and application of a hemagglutination inhibition test for detection of morphine. Clin. Immunol. Immunopathol. 1972; 1: 53–68
   Google Scholar
• Nishikawa T. Nephelometric immunoassay for therapeutic drug level monitoring. Pharm. Res. 1984; 105–109
   PubMed Web of Science ®Google Scholar
• Quattrone A. J., Jones T., Joseph R., Samir S., Selvaggi A., Davenport L. A., Lepoff R. B. A new automated rate nephelometric inhibition immunoassay for carbamezepine. J. Clin. Lab. Auto. 1984; 4: 233–236
   Web of Science ®Google Scholar
• Kohler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495–497
   PubMed Web of Science ®Google Scholar
• Ekins R. Towards immunoassays of greater sensitivity, specificity and speed: an overview. Monoclonal Antibodies and Development in Immunoassay, A. Albertini, R. Ekins. Elsevier/North Holland, Amsterdam 1981; 3–21
   Google Scholar
• Cone R. Application of monoclonal antibodies to clinical diagnostic assays. J Med. Technol. 1985; 2: 279–284
   Google Scholar
• Sevier E. D. Monoclonal antibodies in diagnostic assay systems. J. Med. Technol. 1985; 2: 287–293
   Google Scholar
• Spector S., Parker C. W. Morphine: radioimmunoassay. Science 1970; 168: 1347–1348
   PubMed Web of Science ®Google Scholar
• Spector S. Quantitative determination of morphine in serum by radioimmunoassay. J. Pharmacol. Exp. Ther. 1971; 178: 253–258
   PubMed Web of Science ®Google Scholar
• Spector S., Berkowitz B., Flynn E. J., Peskar B. Antibodies to morphine, barbiturates and serotonin. Pharmacol. Rev. 1973; 25: 281–291
   PubMed Web of Science ®Google Scholar
• Wainer B. H., Fitch F. W., Rothberg R. M., Fried J. Morphine-3-succinyl-bovine serum albumin: an immunogenic hapten-protein conjugate. Science 1972; 176: 1143–1145
   PubMed Web of Science ®Google Scholar
• Gross S. J., Grant J. D., Wong S. R., Schuster R., Lomax P., Campbell D. H. Critical antigenic determinants for production of antibody to distinguish morphine from heroin, codeine and dextromethorphan. Immunochemistry 1974; 11: 453–456
   PubMedGoogle Scholar
• Gintzler A. R., Mohacsi E., Spector S. Radioimmunoassay for the simultaneous determination of morphine and codeine. Eur. J. Pharmacol. 1976; 38: 149–156
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., Butz R. F., Coker G. G., De Angelis R. L., Welch R. M. Triprolidine radioimmunoassay: disposition in animals and humans. J. Pharm. Sci. 1984; 73: 1339–1344
   PubMed Web of Science ®Google Scholar
• Midha K. K., Hubbard J. W., Cooper J. K., Mackonka C. Stereospecific radioimmunoassays for l-ephedrine and d-ephedrine in human plasma. J Pharm. Sci. 1983; 72: 736–739
   PubMed Web of Science ®Google Scholar
• Cook C. E., Ballentine N. H., Seltzman T. B., Tallent C. R. Warfarin enantiomer disposition: determination by stereoselective radioimmunoassay. J Pharmacol. Exp. Ther. 1979; 210: 391–398
   PubMed Web of Science ®Google Scholar
• Wainer B. H., Fitch F. W., Fried J., Rothberg R. M. Immunochemical studies of opioids: specificities of antibodies against codeine and hydromorphone. Clin. Immunol. Im-munopathol. 1974; 3: 155–170
   PubMed Web of Science ®Google Scholar
• Tadepalli S. M., Quinn R. P., Averett D. R. A competitive enzyme-linked immunosorbent assay to quantitate acyclovir levels in human plasma and urine samples. Antimicrob. Agents Chemother. 1986; 29: 93–98
   PubMed Web of Science ®Google Scholar
• Sato S., Yamamoto I. Enzyme immunoassays for β-adrenoreceptor blocking agent, befunolol and its main metabolite, Ml. J. Immunoassay 1983; 4: 351–371
   PubMedGoogle Scholar
• Trivers G. E., Harris C. C., Rougeot C., Dray F. Development and use of ultrasensitive enzyme immunoassays. Meth. Enzymol. 1983; 103: 409–434
   PubMed Web of Science ®Google Scholar
• Schwenzer K. S., Anhalt J. P. Automated fluorescence polarization immunoassay for monitoring streptomycin. Antimirob. Agents Chemother. 1983; 23: 683–687
   PubMed Web of Science ®Google Scholar
• Sheehan M., Caron G. Evaluation of an automated system (Optimate) for substrate-labeled fluorescent immunoassays. Ther. Drug Monit. 1985; 7: 108–114
   PubMed Web of Science ®Google Scholar
• Glasel J. A., Bradbury W. M., Venn R. F. Properties of murine anti-morphine antibodies. Mol. Immunol. 1983; 20: 1419–1422
   PubMed Web of Science ®Google Scholar
• Yeung P. F. K., Mc Kay G., Ramshaw I. A., Hubbard J. W., Midha K. K. A comparison of two radioimmunoassays for 7-hydroxychlorpromazine: rabbit polyclonal antibodies vs. mouse monoclonal antibodies. J. Pharmacol. Exp. Ther. 1985; 233: 816–822
   PubMed Web of Science ®Google Scholar
• Krasny H. C., De Miranda P., Blum M. R., Elion G. B. Pharmacokinetics and bioavailability of acylovir in the dog. J. Pharmacol. Exp. Ther. 1981; 216: 281–288
   PubMed Web of Science ®Google Scholar
• De Miranda P., Whitley R. J., Blum M. R., Keeney R. E., Barton N., Cocchetto D. M., Good S., Hemstreet G. P., Kirk L. E., Page D. A., Elion G. B. Acyclovir kinetics after intravenous infusion. Clin. Pharmacol. Ther. 1979; 26: 718–728
   PubMed Web of Science ®Google Scholar
• Hehir M., Du Vivier A., Eilon L., Danie M. J., Shenoy E. V. B. Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment. Clin. Exp. Dermatol. 1983; 8: 143–151
   PubMed Web of Science ®Google Scholar
• Anik Rae S. T., Mc G., Nerenberg C., Worden A., Foreman J., Hwang J.-T., Kuchinsky S., Jones R. E., Vikery B. Nasal absorption of nafarelin acetate, the decapeptide [D-Nal (2)6] LHRH, in rhesus monkeys. I. J. Pharm. Sci. 1984; 73: 684–685
   PubMed Web of Science ®Google Scholar
• Fuller R. W., Collier J. G. The pharmacokinetic assessment of sodium cromoglycate. J. Pharm. Pharmacol. 1983; 35: 289–292
   PubMed Web of Science ®Google Scholar
• Midha K. K., Rauw G., Mc Kay G., Cooper J. K., Mc Vittie J. Subnanogram quantitation of chlorpheniramine in plasma by a new radioimmunoassay and comparison with a liquid chromatographic method. J. Pharm. Sci. 1984; 69: 1144–1147
   Google Scholar
• Cook C. E., Williams D. L., Myers M., Tallent C. R., Leeson G. A., Okerholm R. A., Wright G. J. Radioimmunoassay for terfenadine in human plasma. J. Pharm. Sci. 1980; 69: 1419–1423
   PubMed Web of Science ®Google Scholar
• Chang R. L., Wood A. W., Dixon W. R., Conney A. H., Anderson K. E., Eiseman J., Alvares A. P. Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. Clin. Pharmacol Ther. 1976; 20: 219–226
   PubMed Web of Science ®Google Scholar
• Dixon R., Lucek R., Todd D., Walser A. Midazolam: radioimmunoassay for phamacokinetic studies in man. Res. Commun. Chem. Pathol. Pharmacol. 1982; 37: 11–20
   PubMedGoogle Scholar
• Dixon R., Carbone J., Tilley J., Liu Y-Y. Radioimmunoassay for the new antiarrhythmic agent cibenzoline in human plasma. J Pharm. Sci. 1983; 72: 100–101
   PubMed Web of Science ®Google Scholar
• Michiels M., Hendriks R., Heykants J. Radioimmunoassay of the new opiate analgesics alfentanil and sufentanil. Preliminary pharmacokinetic profile in man. J. Pharm. Pharmacol. 1983; 35: 86–93
   PubMed Web of Science ®Google Scholar
• Yeung P. F. K., Hubbard J. W., Cooper J. K., Midha K. K. A study of the kinetics of chlorpromazine sulfoxide by a specific radioimmunoassay after a single oral dose of chlorpromazine in healthy volunteers. J. Pharmacol. Exp. Ther. 1983; 226: 833–838
   PubMed Web of Science ®Google Scholar
• Aravagiri M., Hawes E. M., Midha K. K. Radioimmunoassay for the sulfoxide metabolite of trifluoperazine and its application to a kinetic study in humans. J. Pharm. Sci. 1984; 73: 1383–1387
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., De Angelis R. L., Kearney M. F., Welch R. M., Findlay J. M. Analgesic drugs in breast milk and plasma. Clin. Pharmacol. Ther. 1981; 29: 625–633
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., Jones E. C., Welch R. M. Radioimmunoassay determination of the absolute oral bioavailabilities and O-demethylation of codeine and hydrocodone in the dog. DrugMetab. Dispos. 1979; 7: 310–314
   PubMed Web of Science ®Google Scholar
• Findlay J. W. A., Fowle A. S. E., Butz R. F., Jones E. C., Weatherley B. C., Welch R. M., Posner J. Comparative disposition of codeine and pholcodine in man after single oral doses. Br. J. Clin. Pharmacol. 1986; 22: 61–71
   PubMed Web of Science ®Google Scholar